Endometrial safety of a novel monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen over six cycles
Author:
Thomas Rabe,Elena Hartschuh,Torsten Wahlstrom,Kornelia Höschen,Simone König
Publication:
Contraception
Copyright © 2010 Elsevier Inc. All rights reserved.